NO961027L - 5-(1-fluorvinyl)-1H-pyrimidin-2,4-dionderivater som er anvendbare som antineoplastiske midler - Google Patents

5-(1-fluorvinyl)-1H-pyrimidin-2,4-dionderivater som er anvendbare som antineoplastiske midler

Info

Publication number
NO961027L
NO961027L NO961027A NO961027A NO961027L NO 961027 L NO961027 L NO 961027L NO 961027 A NO961027 A NO 961027A NO 961027 A NO961027 A NO 961027A NO 961027 L NO961027 L NO 961027L
Authority
NO
Norway
Prior art keywords
fluorovinyl
pyrimidine
antineoplastic agents
dione derivatives
derivatives useful
Prior art date
Application number
NO961027A
Other languages
English (en)
Other versions
NO961027D0 (no
NO306348B1 (no
Inventor
James Ray Mccarthy
Donald Paul Matthews
Jeffrey Stephen Sabol
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/236,599 external-priority patent/US5512678A/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO961027L publication Critical patent/NO961027L/no
Publication of NO961027D0 publication Critical patent/NO961027D0/no
Publication of NO306348B1 publication Critical patent/NO306348B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO961027A 1993-09-14 1996-03-13 5-(1-fluorvinyl)-1H-pyrimidin-2,4-dionderivater som er anvendbare som antineoplastiske midler NO306348B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12140593A 1993-09-14 1993-09-14
US08/236,599 US5512678A (en) 1993-09-14 1994-04-29 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
PCT/US1994/009502 WO1995007917A1 (en) 1993-09-14 1994-08-23 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents

Publications (3)

Publication Number Publication Date
NO961027L true NO961027L (no) 1996-03-13
NO961027D0 NO961027D0 (no) 1996-03-13
NO306348B1 NO306348B1 (no) 1999-10-25

Family

ID=26819425

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961027A NO306348B1 (no) 1993-09-14 1996-03-13 5-(1-fluorvinyl)-1H-pyrimidin-2,4-dionderivater som er anvendbare som antineoplastiske midler

Country Status (16)

Country Link
EP (1) EP0719271B1 (no)
JP (1) JPH09509137A (no)
CN (1) CN1042429C (no)
AT (1) ATE160571T1 (no)
AU (1) AU690579B2 (no)
CA (1) CA2170608C (no)
DE (1) DE69407056T2 (no)
DK (1) DK0719271T3 (no)
ES (1) ES2111330T3 (no)
FI (1) FI961172A0 (no)
GR (1) GR3026075T3 (no)
HU (1) HUT73414A (no)
IL (1) IL110919A0 (no)
NO (1) NO306348B1 (no)
NZ (1) NZ273161A (no)
WO (1) WO1995007917A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
DE10313035A1 (de) * 2003-03-24 2004-10-07 Resprotect Gmbh Methode zur Verstärkung der apoptotischen Wirkung von Zytostatika ohne Erhöhung toxischer Nebenwirkungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383990A (en) * 1980-10-01 1983-05-17 Beecham Group Limited Antiviral agents, their preparation and use
US5116823A (en) * 1990-02-27 1992-05-26 Roger Williams General Hospital Drug combinations containing AZT
FR2659330B1 (fr) * 1990-03-09 1994-02-11 Sapec Sa Composes diastereoisomeres derivant de l'acide tetrahydrofolique, procede de preparation et utilisation dans la synthese de diastereomeres 6s et 6r de folates reduits.

Also Published As

Publication number Publication date
CN1042429C (zh) 1999-03-10
CA2170608A1 (en) 1995-03-23
IL110919A0 (en) 1994-11-28
DE69407056T2 (de) 1998-04-09
CN1130909A (zh) 1996-09-11
DK0719271T3 (da) 1997-12-29
FI961172L (fi) 1996-03-13
GR3026075T3 (en) 1998-05-29
HUT73414A (en) 1996-07-29
ES2111330T3 (es) 1998-03-01
FI961172A7 (fi) 1996-03-13
JPH09509137A (ja) 1997-09-16
NZ273161A (en) 1997-11-24
HU9600644D0 (en) 1996-05-28
AU690579B2 (en) 1998-04-30
EP0719271B1 (en) 1997-11-26
FI961172A0 (fi) 1996-03-13
NO961027D0 (no) 1996-03-13
ATE160571T1 (de) 1997-12-15
CA2170608C (en) 1999-03-30
EP0719271A1 (en) 1996-07-03
AU7636394A (en) 1995-04-03
DE69407056D1 (en) 1998-01-08
NO306348B1 (no) 1999-10-25
WO1995007917A1 (en) 1995-03-23

Similar Documents

Publication Publication Date Title
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
NO20013379L (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
UA41290C2 (uk) Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам'яті
HUP9802304A2 (hu) Piridazin-3-on-származékok, intermedierjeik, alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid készítmények
DE3781716D1 (de) Mittel zur ortsspezifischen alkylierung.
MX9801129A (es) Agentes farmaceuticos.
NO931366L (no) 1,2,4-oksadiazolylfenoksyalkylisoksazoler og deres anvendelse som antivirale midler
BG101601A (bg) Фармацевтични пиперазинови производни
TR199700354A2 (xx) Karbohidrat t�revleri.
MX9701949A (es) Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales.
NO306348B1 (no) 5-(1-fluorvinyl)-1H-pyrimidin-2,4-dionderivater som er anvendbare som antineoplastiske midler
DK415789D0 (da) Tetracykliske antidepressive midler
TR199801648T2 (xx) Herbisid olarak pirazol-4-il-hetaroil t�revleri
MEP17408A (en) N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
MX9706014A (es) Derivados de xanteno y acridina y su empleo.
DK0596917T3 (da) Benzimidazolanthelmintika
TR200000057T2 (tr) 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları.
ATE123025T1 (de) 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
IL84300A0 (en) 1-carbamoyl-2-pyrazoline derivatives,their preparation and their use as herbicides
CO4940468A1 (es) Nuevos derivados de naftilpiperacina
DK1230223T3 (da) Oligobenzimidazolderivater og deres anvendelse som midler til DNA-transfektion
TW369540B (en) New adenylate analogs derivatives and usage thereof